Skip to content

Clinical trials

Osteosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Clear all

469 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200112
20026
20035
20047
200510
20067
200716
200817
200913
201020
20119
20129
201313
201419
201511
201614
201724
201824
201921
202024
202131
202223
202322
202431
202512
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed207
Recruiting87
Unknown status57
Terminated41
Active, not recruiting38
Withdrawn15
Not yet recruiting14
Suspended5
Available2
No longer available1
Enrolling by invitation1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)54
Children's Oncology Group28
Peking University People's Hospital26
Memorial Sloan Kettering Cancer Center21
St. Jude Children's Research Hospital19
M.D. Anderson Cancer Center12
Emory University8
Istituto Ortopedico Rizzoli7
Italian Sarcoma Group7
Second Affiliated Hospital, Zhejiang University, School of Medicine6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma469
Sarcoma193
Neuroblastoma116
Sarcoma, Ewing114
Rhabdomyosarcoma93
Neuroectodermal Tumors, Primitive, Peripheral70
Wilms Tumor59
Medulloblastoma49
Bone Neoplasms43
Chondrosarcoma43

Trials

Showing 51 to 75 of 469. Each trial links to its page on Pharma Observatory.

369 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.